Tesla Debuts Enhanced Autopilot in China for Just $98 Monthly 
China Beat South Korea in OLED Panel Shipments for Small Gadgets 
Tesla Clears Regulatory Hurdles for FSD Launch in China with Baidu's Help 
Mainland China Investors Blocked from Accessing New Hong Kong Bitcoin ETFs 
Court Documents Unveil $1 Billion Annual Revenue of Shell's Oil Trading Business in US 
Maersk to Invest $600 Million in Nigerian Seaport Infrastructure 
Musk Engages China: Baidu’s Data Deal and High-Stakes Hotel Meet with CATL 
McDonald's Korea Announces Price Hike Amid Record Revenue 
Philips Settles US Ventilator Recall Litigation for $1.1 Billion 
Vivendi Reveals Assessment to Split the Company is Ongoing 
McDonald's Korea Launches 'Mom's Bed' Campaign Highlighting Caregiver Hardships 
Walmart’s Director and Heir Rob Walton to Step Down From Board 
DeepL Unleashes AI-Powered Tool for Business Writing 
LG Uplus, Kakao Mobility EV Charging Joint Venture Approved by the FTC 
Billionaire Moves to Take L’Occitane Private in a $7 Billion Deal 
KT Innovates Media, Content Business Through AI 
DJI Faces Possible US Ban by Congress, Echoing Concerns Over TikTok and China 
NEW YORK, Oct. 31, 2017 -- The Nasdaq Stock Market® (Nasdaq:NDAQ) announced that trading in INSYS Therapeutics, Inc. (Nasdaq:INSY) is scheduled to resume today, Tuesday, October 31, 2017 at 10:00:00 a.m., Eastern Time. Trading in the company’s stock was halted on October 26, 2017 at 16:55:13 Eastern Time.
For news and additional information about the company, please contact the company directly or check under the company’s symbol using InfoQuotesSM on the Nasdaq® Web site.
For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com.
NDAQO
Nasdaq Media Contact:
Christine Barna
[email protected]
